‹ All Posts
Adarsh Nimborkar

17th Nov · SEBI Registration INA000019789

TTK Healthcare Ltd Company Fundamental Analysis

TTKHLTCARE TTK Healthcare is a diversified healthcare and consumer products company with operations across several segments, including medical devices, pharmaceuticals, animal welfare, consumer products and foods. Its portfolio includes artificial heart valves under the TTK Chitra brand, orthopaedic implants, endovascular stents, Woodward’s Gripe Water, Skore condoms and Fryums snacks. This diversification provides multiple revenue streams, but also makes the company less of a pure-play healthcare business. For Q2 FY27, revenue from operations increased 14.6% YoY to ₹233.4 crore, compared with ₹203.6 crore. However, profit before exceptional items and tax declined to ₹19.7 crore from ₹21.3 crore, while operating profit fell 56.5% YoY. Reported net profit jumped to ₹223 crore, but this was primarily due to a ₹248.2 crore exceptional gain arising from the sale of the EVA and Good Home brands to Wipro Enterprises. The company received approximately ₹256 crore plus GST in cash from the brand sale. This strengthens its financial flexibility, but investors should monitor how the proceeds are deployed and whether the remaining business can improve operating profitability. The September 2026 balance sheet indicators show very low debt, with debt-to-equity around 0.02. However, ROE is only around 5–6%, indicating that the company is currently generating modest returns on shareholder capital. TTK Healthcare has a diversified business, a relatively debt-free balance sheet and has received substantial cash from the brand divestment. However, the latest quarterly profit is misleading if viewed without the exceptional gain. The key trigger for a sustainable re-rating will be improvement in core operating margins and returns on capital. At present, the low P/E alone is not a sufficient reason to consider the stock undervalued.

#StockInNews#EquityResearch#HiddenGems#FundamentalViews#WatchOutFor
184 likes·56 comments